Organometallic Bridge Diversification of Bicyclo[1.1.1]pentanes.

Bicyclo[1.1.1]pentanes Bioisostere Strained molecules lithiation small-ring systems

Journal

Chemistry (Weinheim an der Bergstrasse, Germany)
ISSN: 1521-3765
Titre abrégé: Chemistry
Pays: Germany
ID NLM: 9513783

Informations de publication

Date de publication:
20 Dec 2023
Historique:
revised: 19 12 2023
received: 07 12 2023
accepted: 19 12 2023
medline: 20 12 2023
pubmed: 20 12 2023
entrez: 20 12 2023
Statut: aheadofprint

Résumé

Bicyclo[1.1.1]pentane (BCP) derivatives have attracted significant recent interest in drug discovery as alkyne, tert-butyl and arene bioisosteres, where their incorporation is frequently associated with increased compound solubility and metabolic stability. While strategies for functionalisation of the bridgehead (1,3) positions are extensively developed, platforms allowing divergent substitution at the bridge (2,4,5) positions remain limited. Recent reports have introduced 1-electron strategies for arylation and incorporation of a small range of other substituents, but are limited in terms of scope, yields or practical complexity. Herein, we show the synthesis of diverse 1,2,3-trifunctionalised BCPs through lithium-halogen exchange of a readily accessible BCP bromide. When coupled with medicinally relevant product derivatisations, our developed 2-electron "late stage" approach provides rapid and straightforward access to unprecedented BCP structural diversity (>20 hitherto-unknown motifs reported). Additionally, we describe a method for the synthesis of enantioenriched "chiral-at-BCP" bicyclo[1.1.1]pentanes through a novel stereoselective bridgehead desymmetrisation.

Identifiants

pubmed: 38117748
doi: 10.1002/chem.202304070
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e202304070

Informations de copyright

© 2023 Wiley-VCH GmbH.

Auteurs

Joseph M Anderson (JM)

GSK plc, Medicinal Chemistry, UNITED KINGDOM.

Darren L Poole (DL)

GSK plc, Medicinal Chemistry, UNITED KINGDOM.

Gemma C Cook (GC)

GSK plc, Medicinal Chemistry, UNITED KINGDOM.

John A Murphy (JA)

University of Strathclyde, Chemistry, UNITED KINGDOM.

Nicholas David Measom (ND)

GSK, Medicinal Chemistry, Gunnels Wood Road, SG1 2NH, Stevenage, UNITED KINGDOM.

Classifications MeSH